vaccines

Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 04deca68-dc17-41a1-9866-49a6580b

Public health officials are taking aim at the Food and Drug Administration (FDA), warning it should not bow to political pressure and clear a COVID-19 vaccine before one is ready. The officials say they are unnerved over the pressure cranked up by the president, and worry it will contribute to distrust in the public health system that could actually…

More good news on progress towards an escape route from this pandemic: On Monday, vaccine researchers from Oxford University and the pharmaceutical company AstraZeneca announced results from a “Phase 1/2 trial,” suggesting their product might be able to generate immunity without causing serious harm. Similar, but smaller-scale results, were posted just last week for another…

Leaders and laggards in the COVID-19 vaccine race -- and how likely they are to win approval. When will a COVID-19 vaccine be available? How effective will it be? Those are two of the most pressing questions being asked by many with the number of COVID-19 cases rising in much of the U.S.  Unfortunately, the…

A Chinese state-owned vaccine developer secured regulatory approval to test its coronavirus shots in the United Arab Emirates, making it one of the first among a slew of global efforts to get the greenlight for the final stage of human trials. Beijing-based China National Biotec Group Co. was awarded approval on Tuesday to conduct Phase…